Nature

Ancillary risk information and pharmacogenetic tests: social and policy implications

Pharmacogenetics is the study of the contribution of genes and gene variants to inter-individual variation in drug response. 1 Although the study of genetic determinants of drug response began more ...
Nature

Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions

Purpose: Pharmacogenetic testing can inform drug dosing and selection by aiding in estimating a patient's genetic risk of adverse response and/or failure to respond. Some pharmacogenetic tests may ...
Fierce Healthcare

Research and Markets: Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Supplier Shares and Sales Forecasts for 300 Tests

<0> Research and Markets: Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Supplier Shares and Sales Forecasts for 300 Tests </0> <0> Research and MarketsLaura Wood, Senior ManagerU.S ...